Prof. Abdullah Fayez AlAsmari | أ.د. عبدالله بن فايز الأسمري

Professor of Pharmacology and Toxicology and senior academic leader with 15 years of experience across university research, graduate education governance, drug regulation and national professional licensure. Author of 200+ peer-reviewed publications and book chapters and listed among the world's top 2% of scientists (Elsevier–Stanford). Research centers on cardioprotection, ischemia–reperfusion injury, myocardial bioenergetics, HIF-1α and purinergic signaling, diabetic cardiovascular complications and anticancer drug-induced cardiotoxicity, supported by competitive funding from King Saud University, the Saudi National Institute of Health and the Prince Naif Health Research Center.
Proven institutional leader: Head of Department (2019–2023) and Vice Dean of Graduate Studies for Programs and Initiatives, Deanship of Graduate Studies (2023–2025), chairing university-wide committees on graduate programs, joint and interdisciplinary degrees, postdoctoral and executive-certificate regulations, and program quality. Serves on advisory, licensure and assessment bodies of the Saudi Food and Drug Authority (SFDA) and the Saudi Commission for Health Specialties (SCFHS). Executive leadership education from Harvard University and the University of Oxford.